discount glp 1 GLP-1 costs rise, but there are ways to save on weight-loss drugs Medicare to Cover GLP-1 Drugs

Medicaid Services proposed to expand Medicare Part D and Medicaid to cover weight loss drugs

Rationale Obesity remains a major global health challenge, severely affecting metabolic and cardiovascular health

Bruising after semaglutide injections is a common side effect that occurs when the needle damages small blood vessels under the skin

In 2024, researchers published a study demonstrating programmable microneedle technology capable of sustained semaglutide delivery, highlighting the potential of transdermal GLP-1 administration

Insurance coverage for GLP-1 medications varies by condition and plan

Medicare Part D currently does NOT cover GLP-1 receptor agonists for weight loss or obesity aloneonly for type 2 diabetes